Ptc Therapeutics Inc Revenue per Employee (PTCT), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Ptc Therapeutics inc   (NASDAQ: PTCT)
 

Ptc Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Ptc Therapeutics Inc 's Revenue per employee grew on a trailing twelve month basis to $ 834,622, above the company average.
Within the Healthcare sector Employees of 19 other companies have achieved higher revenue per employee. While Ptc Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 292. Ptc Therapeutics Inc has 991 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PTCT Revenue per Employee (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Revenue Change -76.83 % -22.75 % 7.23 % -4.19 % 459.73 %
Sales per Employee (TTM) $ 834,622 1,746,372 1,795,308 1,780,958 1,788,858
PTCT's Total Ranking # 292 # 0 # 0 # 0 # 426
Seq. Revenue Change 65.51 % -21.96 % 17.96 % -84.79 % 451.71 %

PTCT Company Profile >> Back to PTCT Efficiency Comparisons >> Compare PTCT Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 12
Healthcare Sector # 20
Overall Market # 292

Revenue per Employee Statistics
High Average Low
$ 8,630,100 $ 611,103 $ 23,724
(Jun 30 2019)   (March 31, 2015)



Financial Statements
Ptc Therapeutics Inc 's Revenue MRQ $ 273 Millions Visit PTCT's Income Statement
Ptc Therapeutics Inc 's Revenues TTM $ 827 Millions Visit PTCT's aggregate revenue growth
What are PTCT's Sales? Visit PTCT's Sales by Segment




Other Ratios
Ptc Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PTCT's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PTCT's Competitors
Revenue per Employee for PTCT's Suppliers
Revenue per Employee for PTCT's Customers

You may also want to know
PTCT's Sales Growth Rates PTCT's Pe Price to earnings ratio PTCT's Receivables Turnover Ratio PTCT's Stock Quote
PTCT's Net Income Growth Rates PTCT's Ps Price to Sales ratio PTCT's Sales per Employee PTCT's Asset Turnover Ratio
PTCT's Net Margin PTCT's Pb Price to Book ratio PTCT's Financial Strength Ratios PTCT's Dividend Payout Ratio
Date modified: 2026-09-08T15:11:41+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2026Number of Employees Mar 31 2026
Fennec Pharmaceuticals Inc   1,457,114.29 $ 50.999  Million 35 
Tarsus Pharmaceuticals Inc   1,446,159.46 $ 535.079  Million 370 
Eli Lilly And Company  1,444,990.00 $ 72,249.500  Million 50,000 
Esperion Therapeutics Inc   1,422,598.64 $ 418.244  Million 294 
Krystal Biotech Inc   1,414,589.83 $ 417.304  Million 295 
Acadia Pharmaceuticals Inc   1,372,493.73 $ 1,095.250  Million 798 
Liquidia Corporation  1,333,634.26 $ 288.065  Million 216 
Biogen Inc   1,324,986.67 $ 9,937.400  Million 7,500 
Lantheus Holdings Inc   1,295,200.34 $ 1,545.174  Million 1,193 
Indivior Pharmaceuticals Inc   1,292,000.00 $ 1,292.000  Million 1,000 
Puma Biotechnology Inc   1,269,150.84 $ 227.178  Million 179 
Madrigal Pharmaceuticals Inc   1,237,693.99 $ 1,132.490  Million 915 
Theravance Biopharma inc   1,219,722.22 $ 109.775  Million 90 
Akebia Therapeutics Inc   1,197,958.76 $ 232.404  Million 194 
Supernus Pharmaceuticals inc   1,191,461.66 $ 776.833  Million 652 
Arcutis Biotherapeutics Inc   1,174,079.10 $ 415.624  Million 354 
Heron Therapeutics Inc   1,173,312.50 $ 150.184  Million 128 
Cue Biopharma Inc   1,128,655.17 $ 32.731  Million 29 
Journey Medical Corp  1,115,172.41 $ 64.680  Million 58 
Abbvie Inc   1,102,087.72 $ 62,819.000  Million 57,000 
Travere Therapeutics Inc   1,078,863.18 $ 536.195  Million 497 
Corcept Therapeutics Inc  1,053,556.16 $ 769.096  Million 730 
Biomarin Pharmaceutical Inc  1,006,617.82 $ 3,242.316  Million 3,221 
Scilex Holding Company  995,941.18 $ 33.862  Million 34 
Coya Therapeutics Inc   992,377.00 $ 7.939  Million 8 
Sanara Medtech Inc   989,563.23 $ 106.873  Million 108 
Assembly Biosciences Inc   973,931.51 $ 71.097  Million 73 
Hims and Hers Health Inc   970,301.39 $ 2,369.476  Million 2,442 
Regeneron Pharmaceuticals Inc   968,176.51 $ 14,919.600  Million 15,410 
Ani Pharmaceuticals Inc  952,274.23 $ 923.706  Million 970 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.